CLINICAL_TRIALS
trial_result
· 2018-08-06
Clinical Trial Update: Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib [Phase 3]
Summary
Phase 3 trial evaluating high-dose melphalan with or without bortezomib in AL amyloidosis; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Medical Center | Conditions: AL Amyloidosis | Phase 3 | Status: TERMINATED | Results posted: 2018-08-06